Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression-Reference-Cited by-同舟云学术

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression

Published:2016-05-18 Issue:5 Volume:11 Page:e0154293
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cardona Andrés Felipe,Rojas Leonardo,Wills Beatriz,Arrieta Oscar,Carranza Hernán,Vargas Carlos,Otero Jorge,Cuello Mauricio,Corrales Luis,Martín Claudio,Ortiz Carlos,Franco Sandra,Rosell Rafael,

Funder

Foundation for Clinical and Applied Cancer Research - FICMAC

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012,2012

2. Overview of breast cancer collaborative stage data items—their definitions, quality, usage, and clinical implications: a review of SEER data for 2004–2010;N Howlader;Cancer,2014

3. Cancer: Principles and Practice of Oncology;DC Scrump,2011

4. New driver mutations in non-small-cell lung cancer;W Pao;Lancet Oncol,2011

5. Somatic mutations affect key pathways in lung adenocarcinoma;L Ding;Nature,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uniting Latin America Through Research: How Regional Research Can Strengthen Local Policies, Networking, and Outcomes for Patients With Lung Cancer;American Society of Clinical Oncology Educational Book;2022-07

2. Analysis of the relationship between Ki-67 expression and chemotherapy and prognosis in advanced non-small cell lung cancer;Translational Cancer Research;2020-05

3. Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients;Cancer Chemotherapy and Pharmacology;2019-12-12

4. Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP);Thoracic Cancer;2019-12-12

5. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients;Respiratory Research;2018-08-13